Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has results × fotemustine × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 478 Radiotherapy 319 Bevacizumab 314 Carboplatin 313 pembrolizumab 309 Rituximab 282 Paclitaxel 262 Gemcitabine 257 Cisplatin 254 Dexamethasone 247 Docetaxel 231 fludarabine phosphate 211 Doxorubicin 205 Nivolumab 190 Etoposide 184 Lenalidomide 183 Cytarabine 182 Melphalan 172 Fluorouracil 170 Filgrastim 170 fludarabine 166 Oxaliplatin 166 Capecitabine 156 Calcium Dobesilate 156 Erlotinib Hydrochloride 143 Bortezomib 142 Methotrexate 140 Radiosurgery 138 Granulocyte Colony-Stimulating Factor 135 Leucovorin 131

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01359956 2023-04-11

SICOG 0109

National Cancer Institute, Naples

Phase 3 Completed

269 enrolled 12 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡